Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment [3]

Clinical Endocrinology

Volumn 66, Issue 4, 2007, Pages 604-605

  Müssig, Karsten ^a   Knaus Dittmann, Daniele ^a   Schmidt, Helmut ^b   Mörike, Klaus ^c   Häring, Hans Ulrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; HYDROMORPHONE; MORPHINE; OPIATE; TRAMADOL;

ADRENAL INSUFFICIENCY; ADULT; ANAMNESIS; CASE REPORT; CHRONIC PAIN; CLINICAL FEATURE; CORTICOTROPIN BLOOD LEVEL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESTRADIOL BLOOD LEVEL; FATIGUE; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; LABORATORY TEST; LETTER; LUTEINIZING HORMONE BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SECONDARY AMENORRHEA; SIDE EFFECT; SINGLE DRUG DOSE;

ADRENAL INSUFFICIENCY; ADULT; AMENORRHEA; ANALGESICS, OPIOID; CHRONIC DISEASE; FEMALE; HUMANS; HYDROMORPHONE; PAIN;

EID: 33947220018     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02779.x     Document Type: Letter

References (5)

1. Grabe, H.J., Meyer, C., Hapke, U., Rumpf, H.J., Freyberger, H.J., Dilling, H. & John, U. (2003) Somatoform pain disorder in the general population. Psychotherapy and Psychosomatics, 72, 88-94.
2. Pfeiffer, A. & Herz, A. (1984) Endocrine actions of opioids. Hormone and Metabolic Research, 16, 386-397.
3. Ballantyne, J.C. & Mao, J. (2003) Opioid therapy for chronic pain. New England Journal of Medicine, 349, 1943-1953.
4. Oltmanns, K.M., Fehm, H.L. & Peters, A. (2005) Chronic fentanyl application induces adrenocortical insufficiency. Journal of Internal Medicine, 257, 478-480.
5. Grossman, A., Moult, P.J., Cunnah, D. & Besser, M. (1986) Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man. Neuroendocrinology, 42, 357-360.